ŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ï
‰ïˆõƒƒOƒCƒ“ ‘ã•\ˆ¥ŽA
‘‰ïEŠwpW‰ï
Šw‰ïŽ
’芼
Κ
—˜‰v‘Š”½
–ðˆõ\¬
Ž––±‹ÇˆÄ“à
‹lŽ{݈ꗗ
ŠÖ˜AƒŠƒ“ƒN

@ŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ï‰ïŽ ƒIƒ“ƒ‰ƒCƒ“ƒWƒƒ[ƒiƒ‹

<< Šw‰ïŽ‚Ö–ß‚é
<< ‘O‚̃y[ƒW‚Ö–ß‚é

yŒ´’˜z
isŽq‹{èòŠà‚ɑ΂·‚ép‘O“®’‰»Šw—Ö@‚ÌŽ¡—ÃŒø‰Ê


‰œŽR@‘å•ã, ´…@“Ä, X‰ª@Š², –î“àŒ´@“Ö, ˆË“c@‹Å, –ìŒû@—L¶, ‚‹´@æx, –ì›Ô@K³
º˜a‘åŠw“¡‚ª‹u•a‰@ŽY•wl‰È


Key wordsFneoajuvant chemotherapy, cervical cancer, intraarterial injection, combination chemotherapy, cis-platin

“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‰ï•ñ, 34(4) 483-489, 1997


ˆê”ÊŽÐ’c–@lŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ïŽ––±‹Ç@§102-0083 “Œ‹ž“sç‘ã“c‹æ’¬4-7 ’¬ƒp[ƒNƒTƒCƒhƒrƒ‹402 Š”)MAƒRƒ“ƒxƒ“ƒVƒ‡ƒ“ƒRƒ“ƒTƒ‹ƒeƒBƒ“ƒO“à
TELF03-3288-0993@FAXF03-5275-1192@E-mailFkantorengo@jsog-k.jp
Copyright (C) ˆê”ÊŽÐ’c–@lŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ï